Benefits of New Cholesterol Drug Outweighs Risks and Wins Green Light From US Experts

by Julia Samuel on June 10, 2015 at 4:06 PM

A US advisory panel urged regulators to approve a new cholesterol-lowering drug that reduces mortality from cardiovascular disease.

The panel voted 13 to three in favor, saying that makers Regeneron and Sanofi had shown that the benefits of Praluent (alirocumab) lowering bad cholesterol (LDL-C) outweigh its risks.

Low Saturated Fat and Low Cholesterol Diet

To avoid obesity we must consciously control the quantity and the quality of fat that we eat and our daily intake of fat should contribute no more than 25% of our calories.

Elias Zerhouni, Global research and development president, Sanofi said, "We are pleased with the committee's recommendation to approve Praluent. Our clinical trial program focused on patients with high unmet need in which Praluent delivered significant reductions in LDL-C on top of statins and other lipid-lowering therapies."

The drug, which is injected, works differently from statins. If approved, Praluent would be the first fully human monoclonal antibody targeting the PCSK9 enzyme.

Source: AFP

Cholesterol

Cholesterol is produced by the body (liver) and is essential for normal body functioning.

<< 41-year-old With Deformed Bunion In Both Feet Cured By Scarf...

Higher Autism Rates In Children Born to Teen Moms and Parent... >>

Foods to Avoid to Reduce High Cholesterol

List of food sources that have huge amounts of cholesterol and saturated fats bad for health. Cholesterol-rich foods article briefs about healthy eating tips, exercise, weight management.